46b1182f5305b14426b0d5956c1c31536667b157
test_with_bib.md
| ... | ... | @@ -0,0 +1,240 @@ |
| 1 | +| Gene | Reference | |
|
| 2 | +|:---------:|:-----------------------------:| |
|
| 3 | +| ABL2 | (Russler-Germain et al. 2023) | |
|
| 4 | +| HIST1H2BD | (Krysiak et al. 2017) | |
|
| 5 | +| CPNE8 | (Hübschmann et al. 2021) | |
|
| 6 | +| HIST1H2AG | (Krysiak et al. 2017) | |
|
| 7 | +| BIRC6 | | |
|
| 8 | +| CXCR4 | (Krysiak et al. 2017) | |
|
| 9 | +| STAT6 | (Yildiz et al. 2015) | |
|
| 10 | +| CARD11 | (Morin et al. 2011) | |
|
| 11 | +| ITPKB | | |
|
| 12 | +| ACTG1 | (Hübschmann et al. 2021) | |
|
| 13 | +| HIST1H2BC | (Krysiak et al. 2017) | |
|
| 14 | +| POU2AF1 | (Krysiak et al. 2017) | |
|
| 15 | +| SESN1 | | |
|
| 16 | +| CILP | (Russler-Germain et al. 2023) | |
|
| 17 | +| MEF2C | | |
|
| 18 | +| PRKDC | (Hübschmann et al. 2021) | |
|
| 19 | +| TP53 | (Morin et al. 2011) | |
|
| 20 | +| KLF2 | | |
|
| 21 | +| MYCBP2 | (Hübschmann et al. 2021) | |
|
| 22 | +| BCL7A | (Krysiak et al. 2017) | |
|
| 23 | +| B2M | (Morin et al. 2011) | |
|
| 24 | +| VMA21 | (Hübschmann et al. 2021) | |
|
| 25 | +| BCL10 | (Russler-Germain et al. 2023) | |
|
| 26 | +| DUSP2 | | |
|
| 27 | +| MAP2K1 | (Louissaint et al. 2016) | |
|
| 28 | +| IGLL5 | (Russler-Germain et al. 2023) | |
|
| 29 | +| ZC3H12A | | |
|
| 30 | +| JUP | (Hübschmann et al. 2021) | |
|
| 31 | +| TMEM30A | (Morin et al. 2011) | |
|
| 32 | +| ATP6V1B2 | (Okosun et al. 2016) | |
|
| 33 | +| SOCS1 | | |
|
| 34 | +| CYP2A6 | (Russler-Germain et al. 2023) | |
|
| 35 | +| HIST1H3B | | |
|
| 36 | +| SRRM2 | (Russler-Germain et al. 2023) | |
|
| 37 | +| HIST1H3G | (Krysiak et al. 2017) | |
|
| 38 | +| HIST1H2AM | (Krysiak et al. 2017) | |
|
| 39 | +| GNA13 | (Morin et al. 2011) | |
|
| 40 | +| HIST1H1B | (Krysiak et al. 2017) | |
|
| 41 | +| PPP4C | (Hübschmann et al. 2021) | |
|
| 42 | +| MYD88 | | |
|
| 43 | +| PTPRD | | |
|
| 44 | +| EEF1A1 | (Hübschmann et al. 2021) | |
|
| 45 | +| CCND3 | (Morin et al. 2011) | |
|
| 46 | +| LAPTM5 | (Hübschmann et al. 2021) | |
|
| 47 | +| TNFAIP3 | | |
|
| 48 | +| HIST1H1C | (Morin et al. 2011) | |
|
| 49 | +| GBP7 | (Russler-Germain et al. 2023) | |
|
| 50 | +| XIRP2 | (Russler-Germain et al. 2023) | |
|
| 51 | +| GRM6 | (Russler-Germain et al. 2023) | |
|
| 52 | +| CREBBP | (Pasqualucci et al. 2011) | |
|
| 53 | +| SGK1 | (Morin et al. 2011) | |
|
| 54 | +| CD79B | | |
|
| 55 | +| ATP6AP1 | (Okosun et al. 2016) | |
|
| 56 | +| HNRNPD | | |
|
| 57 | +| OR8H2 | (Russler-Germain et al. 2023) | |
|
| 58 | +| IRF8 | (Morin et al. 2011) | |
|
| 59 | +| ZNF608 | (Krysiak et al. 2017) | |
|
| 60 | +| SHROOM3 | (Russler-Germain et al. 2023) | |
|
| 61 | +| HVCN1 | (Krysiak et al. 2017) | |
|
| 62 | +| TBL1XR1 | | |
|
| 63 | +| CD83 | (Russler-Germain et al. 2023) | |
|
| 64 | +| DTX1 | | |
|
| 65 | +| KLHL6 | (Morin et al. 2011) | |
|
| 66 | +| EBF1 | | |
|
| 67 | +| CD70 | (Russler-Germain et al. 2023) | |
|
| 68 | +| IRF4 | | |
|
| 69 | +| STAB2 | (Russler-Germain et al. 2023) | |
|
| 70 | +| TNFRSF14 | (Cheung et al. 2010) | |
|
| 71 | +| FAS | | |
|
| 72 | +| BTK | (Krysiak et al. 2017) | |
|
| 73 | +| FOXO1 | (Morin et al. 2011) | |
|
| 74 | +| SMARCA4 | (Krysiak et al. 2017) | |
|
| 75 | +| POU2F2 | (Krysiak et al. 2017) | |
|
| 76 | +| RRAGC | | |
|
| 77 | +| KIR3DL1 | (Russler-Germain et al. 2023) | |
|
| 78 | +| HIST1H1D | (Krysiak et al. 2017) | |
|
| 79 | +| BCL2 | (Morin et al. 2011) | |
|
| 80 | +| EGR1 | (Krysiak et al. 2017) | |
|
| 81 | +| ACTB | | |
|
| 82 | +| PZP | (Russler-Germain et al. 2023) | |
|
| 83 | +| GNAI2 | | |
|
| 84 | +| DHX15 | (Hübschmann et al. 2021) | |
|
| 85 | +| ATP6V1A | (Hübschmann et al. 2021) | |
|
| 86 | +| PDS5B | (Hübschmann et al. 2021) | |
|
| 87 | +| BCL6 | | |
|
| 88 | +| HIST1H2BM | (Krysiak et al. 2017) | |
|
| 89 | +| PIM1 | | |
|
| 90 | +| MEF2B | (Morin et al. 2011) | |
|
| 91 | +| EZH2 | (Morin et al. 2010) | |
|
| 92 | +| MAGEC1 | (Russler-Germain et al. 2023) | |
|
| 93 | +| KMT2D | (Morin et al. 2011) | |
|
| 94 | +| ARID1A | (Krysiak et al. 2017) | |
|
| 95 | +| MAP7D1 | (Russler-Germain et al. 2023) | |
|
| 96 | +| DDX3X | | |
|
| 97 | +| MGEA5 | (Hübschmann et al. 2021) | |
|
| 98 | +| MKI67 | (Russler-Germain et al. 2023) | |
|
| 99 | +| HIST1H3I | (Krysiak et al. 2017) | |
|
| 100 | +| CCDC42BPB | (Hübschmann et al. 2021) | |
|
| 101 | +| HIST1H1E | (Krysiak et al. 2017) | |
|
| 102 | +| TMSB4X | | |
|
| 103 | +| TPP1 | (Hübschmann et al. 2021) | |
|
| 104 | +| HLA-B | | |
|
| 105 | +| PCLO | | |
|
| 106 | +| FZR1 | (Hübschmann et al. 2021) | |
|
| 107 | +| S1PR2 | | |
|
| 108 | +| BTG1 | | |
|
| 109 | +| BTG2 | (Morin et al. 2011) | |
|
| 110 | +| HIST1H2BG | (Krysiak et al. 2017) | |
|
| 111 | +| LTB | | |
|
| 112 | +| EP300 | (Pasqualucci et al. 2011) | |
|
| 113 | +| CTSS | (Bararia et al. 2020) | |
|
| 114 | +| HIST1H2AC | (Krysiak et al. 2017) | |
|
| 115 | +| NFKBIA | (Russler-Germain et al. 2023) | |
|
| 116 | +| P2RY8 | | |
|
| 117 | +| RBM6 | (Hübschmann et al. 2021) | |
|
| 118 | +| MYC | | |
|
| 119 | + |
|
| 120 | +<div id="refs" class="references csl-bib-body hanging-indent"> |
|
| 121 | + |
|
| 122 | +<div id="ref-barariaCathepsinAlterationsInduce2020c" class="csl-entry"> |
|
| 123 | + |
|
| 124 | +Bararia, Deepak, Johannes A. Hildebrand, Sebastian Stolz, Sarah Haebe, |
|
| 125 | +Stefan Alig, Christopher P. Trevisani, Francisco Osorio-Barrios, et al. |
|
| 126 | +2020. “Cathepsin S Alterations Induce a Tumor-Promoting Immune |
|
| 127 | +Microenvironment in Follicular Lymphoma.” *Cell Reports* 31 (5): 107522. |
|
| 128 | +<https://doi.org/10.1016/j.celrep.2020.107522>. |
|
| 129 | + |
|
| 130 | +</div> |
|
| 131 | + |
|
| 132 | +<div id="ref-cheungAcquiredTNFRSF14Mutations2010a" class="csl-entry"> |
|
| 133 | + |
|
| 134 | +Cheung, K.-John J., Nathalie A. Johnson, Joslynn G. Affleck, Tesa |
|
| 135 | +Severson, Christian Steidl, Susana Ben-Neriah, Jacqueline Schein, et al. |
|
| 136 | +2010. “Acquired TNFRSF14 Mutations in Follicular Lymphoma Are Associated |
|
| 137 | +with Worse Prognosis.” *Cancer Research* 70 (22): 9166–74. |
|
| 138 | +<https://doi.org/10.1158/0008-5472.CAN-10-2460>. |
|
| 139 | + |
|
| 140 | +</div> |
|
| 141 | + |
|
| 142 | +<div id="ref-hubschmannMutationalMechanismsShaping2021b" |
|
| 143 | +class="csl-entry"> |
|
| 144 | + |
|
| 145 | +Hübschmann, Daniel, Kortine Kleinheinz, Rabea Wagener, Stephan H. |
|
| 146 | +Bernhart, Cristina López, Umut H. Toprak, Stephanie Sungalee, et al. |
|
| 147 | +2021. “Mutational Mechanisms Shaping the Coding and Noncoding Genome of |
|
| 148 | +Germinal Center Derived <span class="nocase">B-cell</span> Lymphomas.” |
|
| 149 | +*Leukemia* 35 (7): 2002–16. |
|
| 150 | +<https://doi.org/10.1038/s41375-021-01251-z>. |
|
| 151 | + |
|
| 152 | +</div> |
|
| 153 | + |
|
| 154 | +<div id="ref-krysiakRecurrentSomaticMutations2017b" class="csl-entry"> |
|
| 155 | + |
|
| 156 | +Krysiak, Kilannin, Felicia Gomez, Brian S. White, Matthew Matlock, |
|
| 157 | +Christopher A. Miller, Lee Trani, Catrina C. Fronick, et al. 2017. |
|
| 158 | +“Recurrent Somatic Mutations Affecting <span |
|
| 159 | +class="nocase">B-cell</span> Receptor Signaling Pathway Genes in |
|
| 160 | +Follicular Lymphoma.” *Blood* 129 (4): 473–83. |
|
| 161 | +<https://doi.org/10.1182/blood-2016-07-729954>. |
|
| 162 | + |
|
| 163 | +</div> |
|
| 164 | + |
|
| 165 | +<div id="ref-louissaintPediatrictypeNodalFollicular2016a" |
|
| 166 | +class="csl-entry"> |
|
| 167 | + |
|
| 168 | +Louissaint, Abner, Kristian T. Schafernak, Julia T. Geyer, Alexandra E. |
|
| 169 | +Kovach, Mahmoud Ghandi, Dita Gratzinger, Christine G. Roth, et al. 2016. |
|
| 170 | +“Pediatric-Type Nodal Follicular Lymphoma: A Biologically Distinct |
|
| 171 | +Lymphoma with Frequent MAPK Pathway Mutations.” *Blood* 128 (8): |
|
| 172 | +1093–1100. <https://doi.org/10.1182/blood-2015-12-682591>. |
|
| 173 | + |
|
| 174 | +</div> |
|
| 175 | + |
|
| 176 | +<div id="ref-morinSomaticMutationsAltering2010a" class="csl-entry"> |
|
| 177 | + |
|
| 178 | +Morin, Ryan D., Nathalie A. Johnson, Tesa M. Severson, Andrew J. |
|
| 179 | +Mungall, Jianghong An, Rodrigo Goya, Jessica E. Paul, et al. 2010. |
|
| 180 | +“Somatic Mutations Altering EZH2 (Tyr641) in Follicular and Diffuse |
|
| 181 | +Large <span class="nocase">B-cell</span> Lymphomas of Germinal-Center |
|
| 182 | +Origin.” *Nature Genetics* 42 (2): 181–85. |
|
| 183 | +<https://doi.org/10.1038/ng.518>. |
|
| 184 | + |
|
| 185 | +</div> |
|
| 186 | + |
|
| 187 | +<div id="ref-morinFrequentMutationHistonemodifying2011" |
|
| 188 | +class="csl-entry"> |
|
| 189 | + |
|
| 190 | +Morin, Ryan D., Maria Mendez-Lago, Andrew J. Mungall, Rodrigo Goya, |
|
| 191 | +Karen L. Mungall, Richard D. Corbett, Nathalie A. Johnson, et al. 2011. |
|
| 192 | +“Frequent Mutation of Histone-Modifying Genes in Non-Hodgkin Lymphoma.” |
|
| 193 | +*Nature* 476 (7360): 298–303. <https://doi.org/10.1038/nature10351>. |
|
| 194 | + |
|
| 195 | +</div> |
|
| 196 | + |
|
| 197 | +<div id="ref-okosunRecurrentMTORC1activatingRRAGC2016a" |
|
| 198 | +class="csl-entry"> |
|
| 199 | + |
|
| 200 | +Okosun, Jessica, Rachel L. Wolfson, Jun Wang, Shamzah Araf, Lucy |
|
| 201 | +Wilkins, Brian M. Castellano, Leire Escudero-Ibarz, et al. 2016. |
|
| 202 | +“Recurrent <span class="nocase">mTORC1-activating RRAGC</span> Mutations |
|
| 203 | +in Follicular Lymphoma.” *Nature Genetics* 48 (2): 183–88. |
|
| 204 | +<https://doi.org/10.1038/ng.3473>. |
|
| 205 | + |
|
| 206 | +</div> |
|
| 207 | + |
|
| 208 | +<div id="ref-pasqualucciInactivatingMutationsAcetyltransferase2011a" |
|
| 209 | +class="csl-entry"> |
|
| 210 | + |
|
| 211 | +Pasqualucci, Laura, David Dominguez-Sola, Annalisa Chiarenza, Giulia |
|
| 212 | +Fabbri, Adina Grunn, Vladimir Trifonov, Lawryn H. Kasper, et al. 2011. |
|
| 213 | +“Inactivating Mutations of Acetyltransferase Genes in <span |
|
| 214 | +class="nocase">B-cell</span> Lymphoma.” *Nature* 471 (7337): 189–95. |
|
| 215 | +<https://doi.org/10.1038/nature09730>. |
|
| 216 | + |
|
| 217 | +</div> |
|
| 218 | + |
|
| 219 | +<div id="ref-russler-germainMutationsAssociatedProgression2023b" |
|
| 220 | +class="csl-entry"> |
|
| 221 | + |
|
| 222 | +Russler-Germain, David A., Kilannin Krysiak, Cody A. Ramirez, Matthew |
|
| 223 | +Mosior, Marcus P. Watkins, Felicia Gomez, Zachary L. Skidmore, et al. |
|
| 224 | +2023. “Mutations Associated with Progression in Follicular Lymphoma |
|
| 225 | +Predict Inferior Outcomes at Diagnosis: Alliance A151303.” *Blood |
|
| 226 | +Advances* 7: 5524–39. |
|
| 227 | +<https://doi.org/10.1182/bloodadvances.2023010779>. |
|
| 228 | + |
|
| 229 | +</div> |
|
| 230 | + |
|
| 231 | +<div id="ref-yildizActivatingSTAT6Mutations2015c" class="csl-entry"> |
|
| 232 | + |
|
| 233 | +Yildiz, Mehmet, Hongxiu Li, Denzil Bernard, Nisar A. Amin, Peter |
|
| 234 | +Ouillette, Siân Jones, Kamlai Saiya-Cork, et al. 2015. “Activating STAT6 |
|
| 235 | +Mutations in Follicular Lymphoma.” *Blood* 125 (4): 668–79. |
|
| 236 | +<https://doi.org/10.1182/blood-2014-06-582650>. |
|
| 237 | + |
|
| 238 | +</div> |
|
| 239 | + |
|
| 240 | +</div> |